UE LifeSciences
Philadelphia
About UE LifeSciences
Growth-stage FemTech company in preventive oncology space with proven B2B product suite & promising pipeline. Hallmark product regulatory cleared, validated through independent trials & commercially scaling in multiple markets with high-margin, pay-per-use revenue model. Big Pharma collaboration opening national-scale markets. Strong product pipeline in breast and cervical cancer space.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Funding stage: Seed
- Last round: Seed (Nov 2021)
- Website: uelifesciences.com
- Phone: +12674773252
Industries & Categories
Health Diagnostics, Medical Device, Oncology, Personal Health, Primary and Urgent Care
Social Profiles
Canonical: https://fsome.com/organization/ue-lifesciences-19135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.